PHIO Q2 2023 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$49,000

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-13.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$94,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$2M

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$49,000	-$1M	+96.2%
Operating Income	-$3M	-$3M	-1.0%
Net Income	-$3M	-$3M	-0.7%